These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38008454)

  • 1. Efficacy of Upadacitinib As a Second-line JAK Inhibitor in Ulcerative Colitis: A Case Series.
    Hosomi S; Nishida Y; Fujiwara Y
    Intern Med; 2024 Jul; 63(13):1882-1885. PubMed ID: 38008454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis.
    Nakamura N; Honzawa Y; Ohtsu T; Sano Y; Ito Y; Fukata N; Fukui T; Naganuma M
    Clin J Gastroenterol; 2024 Aug; 17(4):654-657. PubMed ID: 38683411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.
    Hindmarch DC; Malashanka S; Shows DM; Clarke AS; Lord JD
    J Crohns Colitis; 2024 Apr; 18(4):628-637. PubMed ID: 37855324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Sandborn WJ; Ghosh S; Panes J; Schreiber S; D'Haens G; Tanida S; Siffledeen J; Enejosa J; Zhou W; Othman AA; Huang B; Higgins PDR
    Gastroenterology; 2020 Jun; 158(8):2139-2149.e14. PubMed ID: 32092309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of JAK inhibitors in Ulcerative Colitis.
    Ferrante M; Sabino J
    J Crohns Colitis; 2020 Aug; 14(Supplement_2):S737-S745. PubMed ID: 31879750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib.
    Odah T; Karime C; Desai A; Picco MF; Kinnucan JA; Hashash JG; Farraye FA
    Dig Dis Sci; 2024 Oct; 69(10):3911-3919. PubMed ID: 39251560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management.
    Caballero-Mateos AM; Cañadas-de la Fuente GA
    World J Gastroenterol; 2024 Sep; 30(35):3942-3953. PubMed ID: 39351053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea.
    Zhang T; Liu X; Zhang L; Jiang X
    Front Immunol; 2024; 15():1416004. PubMed ID: 39044833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the efficacy of individual Janus kinase inhibitors in the treatment of ulcerative colitis for future positioning in inflammatory bowel disease treatment.
    Nakase H
    Immunol Med; 2023 Sep; 46(3):121-130. PubMed ID: 37036140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis.
    Law CCY; Kayal M; Mehandru S; Colombel JF
    Expert Rev Gastroenterol Hepatol; 2023 Feb; 17(2):109-117. PubMed ID: 36681073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy.
    Napolitano M; D'Amico F; Ragaini E; Peyrin-Biroulet L; Danese S
    Drug Des Devel Ther; 2022; 16():1897-1913. PubMed ID: 35747444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of JAK inhibitors in Crohn's Disease.
    Rogler G
    J Crohns Colitis; 2020 Aug; 14(Supplement_2):S746-S754. PubMed ID: 31781755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors.
    Goetsch A; D'Amico F; Allocca M; Fiorino G; Furfaro F; Zilli A; Parigi TL; Radice S; Peyrin-Biroulet L; Danese S
    Expert Opin Pharmacother; 2023 May; 24(7):849-861. PubMed ID: 37038911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
    Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature.
    Ali NM; Shehab MA
    Am J Case Rep; 2023 Nov; 24():e940966. PubMed ID: 37926993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of upadacitinib in the treatment of ulcerative colitis.
    Jordan AA; Higgins PD
    Immunotherapy; 2023 Jul; 15(10):713-727. PubMed ID: 37129377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.
    Saruta M; Kawaguchi I; Ogawa Y; Sanchez Gonzalez Y; Numajiri N; Tang X; Miller R
    J Med Econ; 2024; 27(1):566-574. PubMed ID: 38512101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upadacitinib for the treatment of rheumatoid arthritis.
    Serhal L; Edwards CJ
    Expert Rev Clin Immunol; 2019 Jan; 15(1):13-25. PubMed ID: 30394138
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Effectiveness of Janus Kinase Inhibitors in the Management of Inflammatory Bowel Disease Following Liver Transplantation.
    Con D; Hilley P; Chin S; Corte C; Hafeez B; Testro A; De Cruz P; Choy M; Srinivasan A
    J Crohns Colitis; 2024 Sep; 18(9):1505-1509. PubMed ID: 38502366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series.
    Ribaldone DG; Testa G; Verstockt B; Molnar T; Savarino E; Schmidt C; Vieujean S; Teich N; Meianu C; Juillerat P; Grellier N; Lobaton T
    J Crohns Colitis; 2024 May; 18(5):720-726. PubMed ID: 37965867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.